Caroline Marie Behler MD
Assistant Professor, Medicine, UCSF School of Medicine
Join to View Full Profile
2100 Webster St Ste 225San Francisco, CA 94115
Phone+1 415-923-3012
Fax+1 415-928-4840
Dr. Behler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2004 - 2007- University of California (San Francisco)Residency, Internal Medicine, 2001 - 2004
University of Washington School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2003 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Excellence in Teaching Award Haile T. Debas Academy of Medical Educators, University of California, San Francisco, 2010
- Junior Inductee Alpha Omega Alpha, 2000
- Junior Inductee Phi Beta Kappa, 1993
Clinical Trials
- A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant Start of enrollment: 2007 May 01
- Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 26 citationsThree‐year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphomaAnn S. LaCasce, R. Gregory Bociek, Ahmed Sawas, Paolo Caimi, Edward Agura
British Journal of Haematology. 2020-02-12 - 173 citationsBrentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma.Ann S. LaCasce, R. Gregory Bociek, Ahmed Sawas, Paolo Caimi, Edward Agura
Blood. 2018-07-05 - 1 citationsAnti-Erythropoietin Antibody Associated Pure Red Cell Aplasia Resolved after Liver TransplantationAnnie K. Hung, Jennifer Guy, Caroline M. Behler, Eugene E. Lee
Case Reports in Transplantation. 2015-07-09
Professional Memberships
- Member
- Member
External Links
- Pacific Hematology Oncology Associateshttp://phoamd.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
